Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by billy4325on Apr 11, 2019 3:27pm
80 Views
Post# 29614790

RE:RE:RE:Business Segment financials

RE:RE:RE:Business Segment financials
This quarter definately better than earlier quarters, but it looks to me like it's mainly a timing difference between quarters.  Overall during the year sales are still down 10% (as noted timing fluctuates).  Not good for a "growth" company.  
 
I agree with you that there is potential, but the issue is that it's been like this for years (without results from the potential).  Going forward it looks like it's the same thing, except extra costs including still running both plants, additional R&D, etc.
 
More specific guidance would be great except they've missed their targets in the past on many occasions, so I'm not sure how useful any guidance really is from them.  It really hurts their credibility.  Conference calls would be a massive improvement though.
 
I was a little curious about setting up the future income tax asset as well.  However looking at note 19 they still have about $13 million in unrecognized tax assets expiring between 2026 and 2038.  If they don't think they'll have taxable income in the next 20 years (above what's currently recognized in the tax asset), that is not a good sign. 
Bullboard Posts